140 related articles for article (PubMed ID: 27417501)
1. An engineered avian-origin influenza A virus for pancreatic ductal adenocarcinoma virotherapy.
Pizzuto MS; Silic-Benussi M; Ciminale V; Elderfield RA; Capua I; Barclay WS
J Gen Virol; 2016 Sep; 97(9):2166-2179. PubMed ID: 27417501
[TBL] [Abstract][Full Text] [Related]
2. Oncolytic activity of avian influenza virus in human pancreatic ductal adenocarcinoma cell lines.
Kasloff SB; Pizzuto MS; Silic-Benussi M; Pavone S; Ciminale V; Capua I
J Virol; 2014 Aug; 88(16):9321-34. PubMed ID: 24899201
[TBL] [Abstract][Full Text] [Related]
3. Vesicular stomatitis virus as an oncolytic agent against pancreatic ductal adenocarcinoma.
Murphy AM; Besmer DM; Moerdyk-Schauwecker M; Moestl N; Ornelles DA; Mukherjee P; Grdzelishvili VZ
J Virol; 2012 Mar; 86(6):3073-87. PubMed ID: 22238308
[TBL] [Abstract][Full Text] [Related]
4. Recombinant Immunomodulating Lentogenic or Mesogenic Oncolytic Newcastle Disease Virus for Treatment of Pancreatic Adenocarcinoma.
Buijs P; van Nieuwkoop S; Vaes V; Fouchier R; van Eijck C; van den Hoogen B
Viruses; 2015 Jun; 7(6):2980-98. PubMed ID: 26110582
[TBL] [Abstract][Full Text] [Related]
5. Intertumoral heterogeneity impacts oncolytic vesicular stomatitis virus efficacy in mouse pancreatic cancer cells.
Goad DW; Nesmelova AY; Yohe LR; Grdzelishvili VZ
J Virol; 2023 Sep; 97(9):e0100523. PubMed ID: 37671865
[TBL] [Abstract][Full Text] [Related]
6. Oncolytic vesicular stomatitis virus in an immunocompetent model of MUC1-positive or MUC1-null pancreatic ductal adenocarcinoma.
Hastie E; Besmer DM; Shah NR; Murphy AM; Moerdyk-Schauwecker M; Molestina C; Roy LD; Curry JM; Mukherjee P; Grdzelishvili VZ
J Virol; 2013 Sep; 87(18):10283-94. PubMed ID: 23864625
[TBL] [Abstract][Full Text] [Related]
7. Anti-Tumor Effects of MAPK-Dependent Tumor-Selective Oncolytic Vaccinia Virus Armed with CD/UPRT against Pancreatic Ductal Adenocarcinoma in Mice.
Kurosaki H; Nakatake M; Sakamoto T; Kuwano N; Yamane M; Ishii K; Fujiwara Y; Nakamura T
Cells; 2021 Apr; 10(5):. PubMed ID: 33922406
[TBL] [Abstract][Full Text] [Related]
8. Induction of apoptosis in pancreatic cancer cells by vesicular stomatitis virus.
Felt SA; Moerdyk-Schauwecker MJ; Grdzelishvili VZ
Virology; 2015 Jan; 474():163-73. PubMed ID: 25463614
[TBL] [Abstract][Full Text] [Related]
9. Preclinical evaluation of the gorilla-derived HAdV-B AdV-lumc007 oncolytic adenovirus 'GoraVir' for the treatment of pancreatic ductal adenocarcinoma.
Bots STF; Harryvan TJ; Groeneveldt C; Kinderman P; Kemp V; van Montfoort N; Hoeben RC
Mol Oncol; 2024 May; 18(5):1245-1258. PubMed ID: 38037840
[TBL] [Abstract][Full Text] [Related]
10. Inactivation of the DNA-sensing pathway facilitates oncolytic herpes simplex virus inhibition of pancreatic ductal adenocarcinoma growth.
Zhang N; Guan Y; Li J; Yu J; Yi T
Int Immunopharmacol; 2023 Nov; 124(Pt B):110969. PubMed ID: 37774484
[TBL] [Abstract][Full Text] [Related]
11. Oncolytic virotherapy for pancreatic ductal adenocarcinoma: A glimmer of hope after years of disappointment?
Tassone E; Muscolini M; van Montfoort N; Hiscott J
Cytokine Growth Factor Rev; 2020 Dec; 56():141-148. PubMed ID: 32859494
[TBL] [Abstract][Full Text] [Related]
12. The Present Status of Immuno-Oncolytic Viruses in the Treatment of Pancreatic Cancer.
Haller SD; Monaco ML; Essani K
Viruses; 2020 Nov; 12(11):. PubMed ID: 33213031
[TBL] [Abstract][Full Text] [Related]
13. Expression of GPX4 by oncolytic vaccinia virus can significantly enhance CD8
Wei W; Tian L; Zheng X; Zhong L; Chen Y; Dong H; Zhang G; Wang S; Tong X
Oncoimmunology; 2024; 13(1):2322173. PubMed ID: 38419758
[TBL] [Abstract][Full Text] [Related]
14. First-in-class small molecule potentiators of cancer virotherapy.
Dornan MH; Krishnan R; Macklin AM; Selman M; El Sayes N; Son HH; Davis C; Chen A; Keillor K; Le PJ; Moi C; Ou P; Pardin C; Canez CR; Le Boeuf F; Bell JC; Smith JC; Diallo JS; Boddy CN
Sci Rep; 2016 May; 6():26786. PubMed ID: 27226390
[TBL] [Abstract][Full Text] [Related]
15. Delivery of improved oncolytic adenoviruses by mesenchymal stromal cells for elimination of tumorigenic pancreatic cancer cells.
Kaczorowski A; Hammer K; Liu L; Villhauer S; Nwaeburu C; Fan P; Zhao Z; Gladkich J; Groß W; Nettelbeck DM; Herr I
Oncotarget; 2016 Feb; 7(8):9046-59. PubMed ID: 26824985
[TBL] [Abstract][Full Text] [Related]
16. Etoposide enhances antitumor efficacy of MDR1-driven oncolytic adenovirus through autoupregulation of the MDR1 promoter activity.
Su BH; Shieh GS; Tseng YL; Shiau AL; Wu CL
Oncotarget; 2015 Nov; 6(35):38308-26. PubMed ID: 26515462
[TBL] [Abstract][Full Text] [Related]
17. Genetic Modification of Oncolytic Newcastle Disease Virus for Cancer Therapy.
Cheng X; Wang W; Xu Q; Harper J; Carroll D; Galinski MS; Suzich J; Jin H
J Virol; 2016 Jun; 90(11):5343-5352. PubMed ID: 27009956
[TBL] [Abstract][Full Text] [Related]
18. A Naturally Occurring Deletion in the Effector Domain of H5N1 Swine Influenza Virus Nonstructural Protein 1 Regulates Viral Fitness and Host Innate Immunity.
Wang J; Zeng Y; Xu S; Yang J; Wang W; Zhong B; Ge J; Yin L; Bu Z; Shu HB; Chen H; Lei CQ; Zhu Q
J Virol; 2018 Jun; 92(11):. PubMed ID: 29563291
[TBL] [Abstract][Full Text] [Related]
19. Viro-immune therapy: A new strategy for treatment of pancreatic cancer.
Ibrahim AM; Wang YH
World J Gastroenterol; 2016 Jan; 22(2):748-63. PubMed ID: 26811622
[TBL] [Abstract][Full Text] [Related]
20. Inducible gene expression in tumors colonized by modified oncolytic vaccinia virus strains.
Stritzker J; Huppertz S; Zhang Q; Geissinger U; Härtl B; Gentschev I; Szalay AA
J Virol; 2014 Oct; 88(19):11556-67. PubMed ID: 25056902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
